Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains

BMC Genomics

Volumn 7, Issue , 2006, Pages

  Liu, Qing Yan ^a   Sooknanan, Roy R ^b   Malek, Lawrence T ^c   Ribecco Lutkiewicz, Maria ^a   Lei, Joy X ^a   Shen, Hui ^a   Lach, Boleslaw ^d   Walker, P Roy ^a   Martin, Joel ^a   Sikorska, Marianna ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c Osteopharm Inc   (Canada)

^d HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BETA 3; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ALPHA SYNUCLEIN; ANKYRIN; ANKYRIN 2; BETA1 INTEGRIN; BINDING PROTEIN; COMPLEMENTARY DNA; FORMIN BINDING PROTEIN 2; INTEGRIN LINKED KINASE; LAMIN A; LAMIN C; MESSENGER RNA; PROTEIN KINASE C EPSILON; PROTEIN S20; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REELIN; REGULATOR PROTEIN; RIBOSOME PROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BII; SPECTRIN; SUPPRESSIN; SYNAPTOTAGMIN; SYNAPTOTAGMIN IV; TRIOSEPHOSPHATE ISOMERASE; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME E2B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; COMPUTER PROGRAM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA RNA HYBRIDIZATION; DOWN REGULATION; DOWN SYNDROME; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TECHNOLOGY; HOUSEKEEPING GENE; HUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SUBTRACTIVE TRANSCRIPTION BASED AMPLIFICATION OF MRNA; UNINDEXED SEQUENCE; UPREGULATION;

3' UNTRANSLATED REGIONS; ALZHEIMER DISEASE; BRAIN; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; GENES; HUMANS; NERVE TISSUE PROTEINS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBTRACTION TECHNIQUE; TRANSCRIPTION, GENETIC;

EID: 33751202974     PISSN: 14712164     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-7-286     Document Type: Article

References (87)

1. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ: Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002, 70:462-473.
2. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ: Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000, 48:77-87.
3. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R: A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001, 20:683-695.
4. Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M: Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life 2004, 56:349-354.
5. Pasinetti GM: Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's'disease dementia. J Neurosci Res 2001, 65:471-476.
6. Ho L, Sharma N, Blackman L, Festa E, Reddy G, Pasinetti GM: From proteomics to biomarker discovery in Alzheimer's disease. Brain Res Brain Res Rev 2005, 48:360-369.
7. Marcotte ER, Srivastava LK, Quirion R: cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmocol Ther 2003, 100:63-74.
8. Drmanac S, Stavropoulos NA, Labat I, Vonau J, Hauser B, Scares MB, Drmanac R: Gene-representing cDNA clusters defined by hybridization of 57,419 clones from infant brain libraries with short oligonucleotide probes. Genomics 1996, 37:29-40.
9. Milner RJ, Sutcliffe JG: Gene expression in rat brain. Nucleic Acids Res 1983, 11:5497-5520.
10. Liang P: A decade of differential display. Biotechniques 2002, 33:338-346.
11. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996, 93:6025-6030.
12. Puskas LG, Zvara A, Hackler L Jr, Van Hummelen P: RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques 2002, 32:1330-1340.
13. Wang J, Hu L, Hamilton SR, Coombes KR, Zhang W: RNA amplification strategies for cDNA microarray experiments. Biotechniques 2003, 34:394-400.
14. Khalyfa A, Bourbeau, D, Chen E, Petroulakis E, Pan J, Xu S, Wang E: Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice. J Biol Chem 2001, 276:22915-22922.
15. Richardson JP, Mohammad SS, Pavitt GD: Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. Mol Cell Biol 2004, 24:2352-2363.
16. Saunders AJ, Tanzi RE: Welcome to the complex disease world. Alpha2-macroglobulin and Alzheimer's disease. Exp Neurol 2003, 184:50-53.
17. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM: Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998, 279:242-247.
18. van Slegtenhorst M, Lewis J, Hutton M: The molecular genetics of the tauopathies. Exp Gerontol 2000, 35:461-471.
19. Vidal R, Calero M, Revesz T, Plant G, Ghiso J, Frangione B: Sequence, genomic structure and tissue expression of Human BR13, a member of the BR1 gene family. Gene 2001, 266:95-102.
20. Abdel-Rahman A, Rao MS, Shetty AK: Nestin expression in hippocampal astrocytes after injury depends on the age of the hippocampus. Glio 2004, 47:299-313.
21. Bhargava A, Meijer OC, Dallman MF, Pearce D: Plasma membrane calcium pump isoform 1 gene expression is repressed by corticosterone and stress in rat hippocampus. J Neurosci 2000, 20:3129-3138.
22. Ito M, Depaz I, Wilce P, Suzuki T, Niwa S, Matsumoto I: Expression of human neuronal protein 22, a novel cytaskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci Lett 2005, 378:125-130.
23. Rajgopal Y, Vemuri MC: Ethanol induced changes in cyclin-dependent kinase-5 activity and its activators, P35, P67 (Munc-18) in rat brain. Neurosci Lett 2001, 308:173-176.
24. Sawada K, Young CE, Barr AM, Longworth K, Takahashi S, Arango V, Mann JJ, Dwork AJ, Falkal P, Phillips AG, Honer WG: Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 2002, 7:484-492
25. Shimura H, Schwartz D, Gygi SP, Kosik KS: CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 2004, 279:4869-4876.
26. Sook KM, Hyen BJ, Bae MK, Kim KW: Human rad21 gene, hHR21(SP), is downregulated by hypoxia in human tumor cells. Biochem Biophys Res Commun 2001, 281:1106-1112.
27. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce DA: Reelin signaling is impaired in autism. Biol Psychiatry 2005, 57:777-787.
28. Zhu G, Wang D, Lin YH, McMahon T, Koo EH, Messing RC: Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase. Biochem Biophys Res GDmmun 2001, 285:997-1006.
29. Duguid JR, Bohmont CW, Liu NG, Tourtellotte WW: Changes in brain gene expression shared by scraple and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:7260-7264.
30. May PC, Finch CE: Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration., Trends Neurosci 1992, 15:391-396.
31. Mocchegiani E, Giacconi R, Fattoretti P, Casoli T, Cipriano C, Muti E, Malavolta M, DiStefano G, Bertoni-Freddaro C: Metallothionein isoforms (I+II and III) and interleukin-6 in the hippocampus of old rats: may their concomitant increments lead to neurodegeneration? Brain Res Bull 2004, 63:133-142.
32. Takahashi M, Iseki E, Kosaka K: Cdk5 and munc-18/p67 co-localization in early stage neurofilbrillary tangles-bearing neurons in Alzheimer type dementia brains. J Neurol Sci 2000, 172:63-69.
33. Dieterich DC, Buckers TM, Gundelfinger ED, Kreutz MR: Screening for differentially expressed genes in the rat inner retina and optic nerve after optic nerve crush. Neurosci Lett 2002, 317:29-32.
34. Walker PR, Smith B, Liu QY, Famili AF, Valdes JJ. Liu Z, Lach B: Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 2004, 31:137-154.
35. Fonseca S, Hackler J, Zvara A, Ferreira S, Balde A, Dudits D, Pais MS, Puskas LG: Monitoring gene expression along pear fruit development, ripening and senescence using cDNA microarrays. Plant Science 2004, 167:457-469.
36. Kuperstein F, Yakubov E, Dinerman P, Gil S, Eylam R, Salem N Jr, Yavin E: Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 2005, 95:1550-1562.
37. Bigl M, Apelt J, Eschrich K, Schilebs R: Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology. J Neurol Transm 2003, 110:77-94.
38. Fukuda M, Kanno E, Ogata Y, Saegusa C, Kim T, Loh YP, Yamamoto A: Nerve growth factor-dependent sorting of synaptotagmin IV protein to mature dense-core vesicles that undergo calcium-dependent exocytosis in PC12 cells. J Biol Chem 2003, 278:3220-3226.
39. Janz R, Goda Y, Geppert M, Missler M, Sudhof TC: SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 1999, 24:1003-1016.
40. Nixon RA, Saito KI, Grynspan F, Griffin WR. Katayama S, Honda T, Mohan PS, Shea TB, Beermann M: Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann N Y Acad Sci 1994, 747:77-91.
41. Wagner SL, Geddes JW, Cotman CW, Lau AL, Gurwitz D, Isackson PJ, Cunningham DD: Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:8284-8288.
42. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
43. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA: Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alphaenolase and heat shock cognate 71. J Neurochem 2002, 82:1524-1532.
44. Shen H, Sikorska M, Leblanc J, Walker PR, Liu QY: Oxidative stress regulated expression of Ubiquitin Carboxyl-terminal Hydrolase-L1: Role in cell survival. Apoptosis 2006 in press.
45. Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo MZ, Engles J, Yochem R, Ratovitskii E, Sidransky D, Jen J: Interaction and colocalization of PGP9.5 with JAB 1 and p27(Kip1). Oncogene 2002, 21:3003-3010.
46. Ramanathan M, Hassanain M, Levitt M, Seth A. Tolman JS, Fried VA, Ingoglia NA: Oxidative stress increases ubiquitin - protein conjugates in synaptosomes. Neuroreport 1999, 10:3797-3802.
47. Vannucci SJ, Mummery R, Hawkes RB, Rider CC, Beesley PW: Hypoxia-ischemia induces a rapid elevation of ubiquitin conjugate levels and ubiquitin immunoreactivity in the immature rat brain. J Cereb Blood Flow Metab 1998, 18:376-385.
48. Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996, 55:1083-1088.
49. Macq AF, Goossens F, Maloteaux JM, Octave JN: Overexpression of the myelin basic protein RNA in the cortex of a patient with Alzheimer's disease. Acta Neurol Belg 1989, 89:316.
50. McGeer EG, Yasojima K, Schwab C, McGeer PL: The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases. Neurobiol Aging 2001, 22:843-848.
51. Yesner LM, Huh HY, Pearce SF, Silverstein RL: Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 1996, 16:1019-1025.
52. Connor JR, Menzies SL, St Martin SM, Mufson EJ: A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992, 31:75-83.
53. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L: Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996, 738:265-274.
54. Debril MB, Dubuquoy L, Felge JN, Wahli W, Desvergne B, Auwerx J, Gelman L: Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. J Mol Endocrinol 2005, 35:503-517.
55. Broers JL, Kuijpers HJ, Ostlund C, Worman HJ, Endert J, Ramaekers FC: Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization. Exp Cell Res 2005, 304:582-592.
56. Stankewich MC, Tse WT, Peters LL, Ch'ng Y, John KM, Stabach PR, Devarajan P, Morrow JS, Lux SE: A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles. Proc Natl Acad Sci USA 1998, 95:14158-14163.
57. Avramut M, Achim CL: Immunophilins and their ligands: insights into survival and growth of human neurons. Physiol Behav 2002, 77:463-468.
58. Farah CA, Liazoghli D, Perreault S, Desjardins M, Guimont A. Anton A, Lauzon M, Kreibich G, Paiement J, Lederc N: Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons. J Biol Chem 2005, 280:9439-9449.
59. Cyr JL, Pfister KK. Bloom GS, Slaughter CA, Brady ST: Molecular genetics of kinesin light chains: generation of isoforms by alternative splicing. Proc Natl Acad Sci USA 1991, 88:10114-10118.
60. Zhu X, Raina. AK, Boux H, Simmons ZL, Takeda A, Smith MA: Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 2000, 18:433-437.
61. Nie Z, Stanley KT, Stauffer S, Jacques KM, Hirsch DS, Takei J, Randazzo PA: AGAP1, an endosome-associated, phosphoinositide-dependent ADP-ribosylation factor GTPase-activating protein that affects actin cytoskeleton. J Biol Chem 2002, 277:48965-48975.
62. Madura T, Yamashita T, Kubo T, Tsuji L, Hosokawa K, Tohyama M: Changes in mRNA of Slit-Robo GTPase-activating protein 2 following facial nerve transection. Brain Res Mol Brain Res 2004, 123:76-80.
63. Kremer BE, Haystead T, Macara IG: Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol Biol Cell 2005, 16:4648-4659.
64. de Bruijn B, Martin J: Finding gene function using LitMiner. Proc Text Retrieval Conference (TREC) 2003:451-459.
65. Engidawork E, Gulesserian T, Fountoulakis M, Lubec G: Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience 2003, 122:145-154.
66. Yang LB, Li R, Meri S, Rogers J, Shen Y: Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease. J Neurosci 2000, 20:7505-7509.
67. Liauw J, Nguyen V, Huang J, George-Hyslop P, Rozmahel R: Differential display analysis of presenilin 1-deficient mouse brains. Brain Res Mol Brain Res 2002, 109:56-62.
68. Sorbi S, Mortilla M, Piacentini S, Tonini S, Amaducci L: Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients. Neurosci Lett 1990, 117:165-168.
69. Fernandes ML, Saad MJ, Velloso LA: Effects of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 2001, 16:227-234.
70. Morley JE: The SAMP8 mouse: a model of Alzheimer disease? Biogerontology 2002, 3:57-60.
71. Choi J, Levey Al, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L: Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimers diseases. J Biol Chem 2004, 279:13256-13264.
72. Kurihara LJ, Kikuchi T, Wada K, Tilghman SM: Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia. Hum Mol Genet 2001, 10:1963-1970.
73. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS: Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 2004, 157:163-175.
74. Ferrer I, Barrachina M, Puig B, Martinez dL, Marti E, Avila J, Dierssen M: Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis 2005, 20:392-400.
75. Mathews PM, Guerra CB, Jiang Y, Grbovic OM, Kao BH, Schmidt SD, Dinakar R, Mercken M, Hille-Rehfeld A, Rohrer J, Mehta P, Cataldo AM, Nixon RA: Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis. J Biol Chem 2002, 277:5299-5307.
76. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, Yamamoto T, Okada H, Kosaka K, Sakanaka M, Sawada T: Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 2001, 284:310-316.
77. Yoo BC, Fountoulakis M, Cairns N, Lubec G: Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis 2001, 22:172-179.
78. Fountoulakis M, Cairns N, Lubec G: Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 1999, 57:323-335.
79. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J: Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 2004, 18:152-166.
80. Shin JH, Weitzdoerfer R, Fountoulakis M, Lubec G: Expression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain. Neurochem Int 2004, 45:73-79.
81. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS: Up-regulation of neuronal calcium sensor-1 (NCS-1) In the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci USA 2003, 100:313-317.
82. Rosdahl D, Seitzberg DA, Christensen T, Balchen T, Diemer NH: Changes in mRNA for metabotropic glutamate receptors after transient cerebral ischaemia. Neuroreport 1994, 5:593-596.
83. Perez-Torres S, Cortes R, Tolnay M, Probst A, Palacios JM, Mengod G: Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 2003, 182:322-334.
84. Bai J, He F, Novikova SI, Undie AS, Dracheva S, Haroutunian V, Lidow MS: Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol Psychiatry 2004, 56:427-440.
85. Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J, Mandelkow EM: MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 2003, 22:5090-5101.
86. Pollak D, Weitzdoerfer R, Yang YW, Prast H, Hoeger H, Lubec G: Cerebellar protein expression in three different mouse strains and their relevance for motor performance. Neurochem Int 2005, 46:19-29.
87. Li J, Pauley AM, Myers RL, Shuang R, Brashler JR, Yan R, Buhl AE, Ruble C, Gurney ME: SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production. J Neurochem 2002, 82:1540-1548.